tiprankstipranks
Trending News
More News >
STRATEC Biomedical AG (DE:SBS)
XETRA:SBS
Germany Market

STRATEC Biomedical (SBS) Ratios

Compare
5 Followers

STRATEC Biomedical Ratios

DE:SBS's free cash flow for Q3 2024 was €0.29. For the 2024 fiscal year, DE:SBS's free cash flow was decreased by € and operating cash flow was €0.04. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
3.62 3.51 4.12 4.38 3.62
Quick Ratio
2.05 1.56 2.17 2.47 2.05
Cash Ratio
0.64 0.38 1.03 1.05 0.64
Solvency Ratio
0.24 0.27 0.35 0.27 0.24
Operating Cash Flow Ratio
0.60 0.17 1.39 0.89 0.60
Short-Term Operating Cash Flow Coverage
13.02 2.09 13.47 9.45 13.02
Net Current Asset Value
€ -11.28M€ 39.07M€ 25.25M€ -3.08M€ -11.28M
Leverage Ratios
Debt-to-Assets Ratio
0.31 0.22 0.23 0.33 0.31
Debt-to-Equity Ratio
0.59 0.39 0.41 0.64 0.59
Debt-to-Capital Ratio
0.37 0.28 0.29 0.39 0.37
Long-Term Debt-to-Capital Ratio
0.34 0.23 0.26 0.36 0.34
Financial Leverage Ratio
1.88 1.77 1.79 1.92 1.88
Debt Service Coverage Ratio
12.72 6.98 9.53 10.71 12.72
Interest Coverage Ratio
18.59 22.01 35.49 29.19 18.59
Debt to Market Cap
0.12 0.07 0.05 0.07 0.12
Interest Debt Per Share
7.86 7.34 7.16 9.18 7.86
Net Debt to EBITDA
1.96 1.12 0.58 1.37 1.96
Profitability Margins
Gross Profit Margin
23.51%28.94%30.53%27.58%23.51%
EBIT Margin
7.85%14.92%16.80%13.65%7.85%
EBITDA Margin
16.28%20.95%22.78%21.03%16.28%
Operating Profit Margin
8.62%15.21%17.67%12.99%8.62%
Pretax Profit Margin
8.27%14.23%16.30%13.20%8.27%
Net Profit Margin
6.52%10.64%13.91%10.07%6.52%
Continuous Operations Profit Margin
6.43%10.64%13.91%11.37%6.43%
Net Income Per EBT
78.82%74.76%85.32%76.24%78.82%
EBT Per EBIT
95.87%93.55%92.22%101.65%95.87%
Return on Assets (ROA)
4.82%7.35%10.84%7.59%4.82%
Return on Equity (ROE)
9.08%12.98%19.42%14.59%9.08%
Return on Capital Employed (ROCE)
7.25%12.39%15.73%10.97%7.25%
Return on Invested Capital (ROIC)
6.28%9.07%13.15%9.28%6.28%
Return on Tangible Assets
7.14%9.45%14.31%10.35%7.14%
Earnings Yield
1.97%2.97%2.39%1.70%1.97%
Efficiency Ratios
Receivables Turnover
5.70 4.75 6.97 6.59 5.70
Payables Turnover
13.82 17.96 17.51 21.34 13.82
Inventory Turnover
3.03 1.66 2.25 2.66 3.03
Fixed Asset Turnover
3.96 3.71 4.26 3.82 3.96
Asset Turnover
0.74 0.69 0.78 0.75 0.74
Working Capital Turnover Ratio
2.44 1.87 2.19 2.34 2.44
Cash Conversion Cycle
158.17 276.58 193.84 175.34 158.17
Days of Sales Outstanding
64.06 76.88 52.38 55.35 64.06
Days of Inventory Outstanding
120.52 220.03 162.31 137.09 120.52
Days of Payables Outstanding
26.41 20.32 20.85 17.10 26.41
Operating Cycle
184.58 296.91 214.69 192.44 184.58
Cash Flow Ratios
Operating Cash Flow Per Share
1.77 0.85 5.24 2.64 1.77
Free Cash Flow Per Share
-0.47 -0.72 3.57 0.52 -0.47
CapEx Per Share
2.24 1.57 1.67 2.12 2.24
Free Cash Flow to Operating Cash Flow
-0.26 -0.85 0.68 0.20 -0.26
Dividend Paid and CapEx Coverage Ratio
0.58 0.34 2.04 0.89 0.58
Capital Expenditure Coverage Ratio
0.79 0.54 3.14 1.25 0.79
Operating Cash Flow Coverage Ratio
0.23 0.12 0.74 0.29 0.23
Operating Cash Flow to Sales Ratio
0.10 0.04 0.22 0.13 0.10
Free Cash Flow Yield
-0.76%-0.89%2.59%0.42%-0.76%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
50.66 33.67 41.77 58.84 50.66
Price-to-Sales (P/S) Ratio
3.30 3.58 5.81 5.92 3.30
Price-to-Book (P/B) Ratio
4.60 4.37 8.11 8.58 4.60
Price-to-Free Cash Flow (P/FCF) Ratio
-131.00 -112.57 38.60 236.31 -131.00
Price-to-Operating Cash Flow Ratio
34.40 95.72 26.29 46.51 34.40
Price-to-Earnings Growth (PEG) Ratio
0.64 -1.25 1.15 0.73 0.64
Price-to-Fair Value
4.60 4.37 8.11 8.58 4.60
Enterprise Value Multiple
22.22 18.22 26.08 29.54 22.22
Enterprise Value
802.04M 1.05B 1.71B 1.55B 802.04M
EV to EBITDA
22.22 18.22 26.08 29.54 22.22
EV to Sales
3.62 3.82 5.94 6.21 3.62
EV to Free Cash Flow
-143.63 -119.95 39.48 247.80 -143.63
EV to Operating Cash Flow
37.72 101.99 26.89 48.77 37.72
Tangible Book Value Per Share
5.16 11.29 9.61 6.96 5.16
Shareholders’ Equity Per Share
13.26 18.56 16.99 14.31 13.26
Tax and Other Ratios
Effective Tax Rate
0.12 0.25 0.15 0.14 0.12
Revenue Per Share
18.48 22.64 23.73 20.73 18.48
Net Income Per Share
1.20 2.41 3.30 2.09 1.20
Tax Burden
0.79 0.75 0.85 0.76 0.79
Interest Burden
1.05 0.95 0.97 0.97 1.05
Research & Development to Revenue
0.02 0.03 0.03 0.03 0.02
SG&A to Revenue
0.08 0.07 0.06 0.08 0.08
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 0.02 <0.01
Income Quality
1.47 0.35 1.59 1.27 1.47
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis